FREE Shipping in U.S. for a limited time (except to Alaska & Hawaii) - Take advantage of the significant savings!
You are currently viewing AbsorbAid Clinical Studies by the Mayo Clinic & Roche Labs

AbsorbAid Clinical Studies by the Mayo Clinic & Roche Labs

AbsorbAid® is a unique digestive enzyme. The only one that has been scientifically proven to increase the absorption of vital nutrients by up to 71%. These results come from Mayo Clinic Labs and Roche Labs.

AbsorbAid® is the safer and better option to neutralize stomach acidity and relieve heartburn, indigestion or upset stomach. AbsorbAid® also helps alleviate occasional digestive disturbances such as gas, bloating and belching. †

Abstract 102

Journal of the American College of Nutrition, Vol. 19, No. 5, 700 (2000)
Published by the American College of Nutrition

EFFICACY OF AN ENZYME PRODUCT DERIVED FROM ASPERGILLUS NIGER AND BROMELAIN (ABSORBAID®) IN IMPROVING PROTEIN ABSORPTION IN NURSING HOME PATIENTS ON TUBE FEEDING. Glade MJ, Kendra D, Kaminski MV, Jr. Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, Chicago IL.

The impact of an enzyme-based digestive aid derived from Aspergillus niger and bromelain (AbsorbAid®) on nutritional status was studied in 16 nursing home patients who were bedridden, nourished via enteral intubation and free from episodes of sepsis immediately prior to and following three consecutive 15-day study periods. Following an initial 15-day “run-in” period, and after ensuring that all patients were clinically stable, the 16 patients were given AbsorbAid® (1 teaspoon mixed with water and placed down the feeding tube, 4 times daily) for 15 days. AbsorbAid® was then withdrawn during a 15-day “washout” period. Analysis of variance indicated that total protein concentration improved significantly during AbsorbAid® supplementation (mean increase: 0.32 +/- 0.12 mg/dL; p = 0.02). When the supplement was withdrawn, total protein and albumin concentrations and lymphocyte count returned to pre-treatment levels. Adding AbsorbAid® to the feeding regime of nursing home patients fed via enteral intubation resulted in an improvement in nutritional status as evidenced by a significant improvement in total protein concentration.

Abstract 125
Journal of the American College of Nutrition, Vol. 17, No. 5, 528 (1998)
Published by the American College of Nutrition

ORAL ENZYME SUPPLEMENT IN SHORT BOWEL HOME TPN PATIENTS. Kaminski MV Jr, Jan P. FUHS/Chicago Medical School and Thorek Hospital and Medical Center, Chicago, IL USA.

Eight patients were studied off and on a 7-day course of therapy using a tasteless oral enzyme powder derived from aspergillus and bromelain containing lipase, amylase, protease, cellulase and lactase. One level teaspoon was taken before each meal. Symptoms, number in quality of stools/day/week were determined. A stool analysis for long chain fatty acids (LCFA), total fecal fat (TF), total short chain fatty acids (SCFA), vegetable (V) fiber and meat (M) fiber was done.

Off On Normal
LCFAs 1.9 1.1 (0 to 1.1%)
TF 2.6 1.2 (0 to 1.6%)
TSCFA 81 58 (56-156/mols/g)
V Fiber 8 3 (0-4)
M Fiber 0 0 (0)

These data indicate hyper digestion with improved absorption of oral meals may be possible by using an oral enzyme supplement before each meal. There were no untoward side effects. Improvement ranged from slight to more significant.